OMAHA, Neb., Oct. 2, 2024 /PRNewswire/ -- Ambetter from Nebraska Total Care, a product offered by a Centene Corporation (NYSE: CNC) company, which provides insurance to under-insured and uninsured populations through the federal Health Insurance Marketplace®, will offer Nebraskans a variety of affordable health insurance plans in plan year 2025. Open enrollment for the Health Insurance Marketplace for Nebraska runs from Nov. 1, 2024, through Jan. 15, 2025. Enroll by Dec. 15, 2024, for coverage starting Jan. 1, 2025.
"Ambetter from Nebraska Total Care provides critical health insurance coverage, allowing thousands of Nebraskans the peace of mind that they have the resources to take charge of their health," said Plan President and Chief Executive Officer of Nebraska Total Care, Adam Proctor. "Ambetter from Nebraska Total Care offers a variety of plan options to deliver cost-effective solutions to meet the health needs of each individual, while also providing a member experience that earns five out of five stars from the National Committee for Quality Assurance."
Ambetter from Nebraska Total Care offers its members access to quality care, convenient services and valuable rewards. The 2025 benefits and offerings include:
Ambetter from Nebraska Total Care or enrolling in a health plan during the open enrollment period may visit ambetterhealth.com/en/ne/.
About Ambetter from Nebraska Total Care
Ambetter from Nebraska Total Care serves under-insured and uninsured populations through the federal Health Insurance Marketplace®. Ambetter from Nebraska Total Care is underwritten by Nebraska Total Care, Inc., which is a Qualified Health Plan issuer in Nebraska. For more information, visit ambetterhealth.com/en/ne. This is a solicitation for insurance. For information on your right to receive an Ambetter from Nebraska Total Care plan free of discrimination, or your right to receive language, auditory and/or visual assistance services, please visit ambetterhealth.com/en/ and scroll to the bottom of the page.
Last Trade: | US$63.52 |
Daily Change: | 1.74 2.82 |
Daily Volume: | 5,286,820 |
Market Cap: | US$33.410B |
October 30, 2024 October 25, 2024 September 11, 2024 August 29, 2024 |
Recursion Pharmaceuticals is a clinical stage TechBio company leading the space by decoding biology to industrialize drug discovery. Enabling its mission is the Recursion OS, a platform built across diverse technologies that continuously expands one of the world’s largest....
CLICK TO LEARN MORECompass Therapeutics is a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases. The company's scientific focus is on the relationship between angiogenesis, the immune system, and tumor growth...
CLICK TO LEARN MOREEnd of content
No more pages to load
COPYRIGHT ©2023 HEALTH STOCKS HUB